Evidence map›Paper›PMID 30823440›Full record

ArticleInternational journal of environmental research and public health2019

Evaluating the Integrated Methadone and Anti-Retroviral Therapy Strategy in Tanzania Using the RE-AIM Framework.

Saria Hassan, Alexis Cooke, Haneefa Saleem, Dorothy Mushi, Jessie Mbwambo, Barrot H Lambdin

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Saria HassanYale School of Medicine, Yale University, New Haven, CT 06511, USA. saria.hassan@yale.edu.ORCID 0000-0003-0700-9529
Alexis CookeSan Francisco Department of Psychiatry, University of California, San Francisco, CA 94118, USA. alexis.cooke@ucsf.edu.ORCID 0000-0002-7053-1208
Haneefa SaleemJohns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA. haneefa.saleem@jhu.edu.
Dorothy MushiDepartment of Psychiatry, Muhimbili University of Health and Allied Sciences, Dar-Es-Salaam 11000, Tanzania. dorrymush@yahoo.com.
Jessie MbwamboDepartment of Psychiatry, Muhimbili University of Health and Allied Sciences, Dar-Es-Salaam 11000, Tanzania. jmbwambo@gmail.com.
Barrot H LambdinRTI International, San Francisco, CA 94104, USA. blambdin@rti.org.
Muhimbili University of Health and Allied Sciences · TZJohns Hopkins University · USRTI International · USUniversity of California, San Francisco · USYale University · US

Funding

Substance Use Disorders Treatment/Services Research Training ProgramT32DA007250 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre, Janice Y Tsoh · 1991 to 2026
$7.4M
Scientific and Technical CoreP2CHD041022 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HIRAM BELTRAN-SANCHEZ · 2016 to 2026
$6.9M
UCSF Research in Implementation Sciences for Equity (RISE)R25HL126146 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRYSTAL WILEY CENE, Alicia Fernandez · 2014 to 2026
$4.6M
CALIFORNIA CENTER FOR POPULATION TRAINING PROGRAMT32HD007545 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HIRAM BELTRAN-SANCHEZ, Megan M Sweeney · 2001 to 2026
$4.1M
Yale Scholars in Implementation Science (YSIS)K12HL138037 · NHLBI · YALE UNIVERSITY · PI SHARIFI, MAHNOOSH · 2017 to 2021
$3.0M
Reducing Failure-to-Initiate ART among People Who Inject Drugs: the IMAT StrategyR34DA037787 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI LAMBDIN, BARROT HOPKINS · 2014 to 2016
$585k
NHLBI NIH HHS K12HL138037NHLBI NIH HHS R25 HL126146NICHD NIH HHS P2C HD041022NICHD NIH HHS T32 HD007545NIDA NIH HHS R34 DA037787NIDA NIH HHS T32 DA007250
6 · The paper itself

Abstract

There are an estimated 50,000 people who inject drugs in Tanzania, with an HIV prevalence in this population of 42%. The Integrated Methadone and Anti-Retroviral Therapy (IMAT) strategy was developed to integrate HIV services into an opioid treatment program (OTP) in sub-Saharan Africa and increase anti-retroviral therapy (ART) initiation rates. In this paper, we evaluate the IMAT strategy using an implementation science framework to inform future care integration efforts in the region. IMAT centralized HIV services into an OTP clinic in Dar Es Salaam, Tanzania: HIV diagnosis, ART initiation, monitoring and follow up. A mixed-methods, concurrent design, was used for evaluation: quantitative programmatic data and semi-structured interviews with providers and clients addressed 4 out of 5 components of the RE-AIM framework: reach, effectiveness, adoption, implementation. Results showed high

Indexed as

AdultAnalgesics, OpioidAnti-HIV AgentsDelivery of Health CareDrug Therapy, CombinationFemaleHIV InfectionsHumansMethadoneOpiate Substitution TreatmentPrevalenceSubstance Abuse, IntravenousSubstance Abuse Treatment CentersTanzaniaAnalgesics, OpioidAnti-HIV AgentsMethadoneHIVintegrationkey populationopioidRE-AIMsub-Saharan Africa

Identifiers

PMID30823440
PMCPMC6427450
OpenAlexW2917199571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.